| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/20/1995 | WO1995010300A1 Vibrio cholerae 01 (cvd111) and non-01 (cvd112 and cvd112rm) serogroup vaccine strains and methods of making same |
| 04/20/1995 | WO1995010299A1 COMPOSITION FOR TREATMENT BY IMMUNOTHERAPY OF A CANCER SECRETING hCG OR hCG FRAGMENTS |
| 04/20/1995 | WO1995010265A1 Therapeutic delivery compositions and methods of use thereof |
| 04/20/1995 | CA2622018A1 Cellular and serum protein anchors and conjugates |
| 04/20/1995 | CA2178341A1 Detection and treatment of breast and gynecological cancer |
| 04/20/1995 | CA2174136A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins |
| 04/20/1995 | CA2174132A1 Fas antagonists and uses thereof |
| 04/20/1995 | CA2173606A1 Vibrio cholerae 01 (cvd111) and non-01 (cvd112 and cvd112rm) serogroup vaccine strains, methods of making same and products thereof |
| 04/20/1995 | CA2171546A1 Growth differentiation factor-10 |
| 04/20/1995 | CA2118454A1 Composition for inhibiting ige production |
| 04/19/1995 | EP0648502A1 Live vaccine with enhanced stability |
| 04/19/1995 | EP0648499A1 Composition for inhibiting IgE production |
| 04/19/1995 | EP0648279A1 Acceptor for fucosyltransferase |
| 04/19/1995 | EP0648276A1 Monoclonal antibodies to glycoprotein p |
| 04/19/1995 | EP0648270A1 Cloning of gene encoding the gp28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications |
| 04/19/1995 | EP0648269A1 Novel polypeptides having nmda receptor activity, nucleic acids encoding said polypeptides and applications |
| 04/19/1995 | EP0648261A1 A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
| 04/19/1995 | EP0648260A1 Fusobacterium necrophorum leukotoxoid vaccine |
| 04/19/1995 | EP0648227A1 Improvements in or relating to neuroregeneration |
| 04/19/1995 | EP0648225A1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 04/19/1995 | EP0648128A1 DNA ENCODING PRECURSOR INTERLEUKIN 1$g(b) CONVERTING ENZYME |
| 04/19/1995 | EP0648127A1 Type i and type ii surface antigens associated with staphylococcus epidermidis |
| 04/19/1995 | EP0550683B1 Vaccine suitable for combatting bordetella pertussis |
| 04/19/1995 | EP0407392B1 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES |
| 04/19/1995 | CN1028206C Purification of pertussis antigens |
| 04/18/1995 | US5408041 Multiple elutions with Sepharose, Sephacryl, HPLC; for bone disorders, osteoporosis, Paget*s disease |
| 04/18/1995 | US5407834 Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit |
| 04/18/1995 | US5407833 For forming detectable complexes with autoimmune antibodies, kits |
| 04/18/1995 | US5407823 Polypeptides having a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides for the screening of substances active on these polypeptides |
| 04/18/1995 | US5407805 Monoclonal antibody reactive to various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment |
| 04/18/1995 | CA1335320C Sequential polypeptides endowed with immunological activity |
| 04/18/1995 | CA1335268C Methods of technetium/rhenium labeling of proteins |
| 04/18/1995 | CA1335254C Universally applicable detection system based on ultra small colloidal metal particles |
| 04/13/1995 | WO1995009921A1 Platelet-activating factor acetylhydrolase |
| 04/13/1995 | WO1995009919A1 Vaccines and diagnostics for borrelia burgdorferi |
| 04/13/1995 | WO1995009912A1 Stem cell proliferation factor |
| 04/13/1995 | WO1995009870A1 Characterization of mycoplasma hyopneumoniae adhesins |
| 04/13/1995 | WO1995009657A1 Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained |
| 04/13/1995 | WO1995009655A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines |
| 04/13/1995 | WO1995009653A1 Antibodies to cd40 |
| 04/13/1995 | WO1995009652A1 Treatment of autoimmune and inflammatory disorders |
| 04/13/1995 | WO1995009651A1 Improvements in and relating to vaccines |
| 04/13/1995 | WO1995009650A1 Albumin-conjugated tumour cell-free extracts, antigenic compositions comprising the same, related antibodies, and uses thereof |
| 04/13/1995 | WO1995009649A1 Vaccine compositions |
| 04/13/1995 | WO1995009648A1 Protein- or peptide-cochleate vaccines and methods of immunizing using the same |
| 04/13/1995 | WO1995009643A1 Endothelin activity inhibitor |
| 04/13/1995 | WO1995009642A1 Method for provoking immunity by peptides labelled with a photoactivatable group which binds to mhc molecules |
| 04/13/1995 | WO1995009610A1 Liposomes containing particulate materials |
| 04/13/1995 | WO1995007934A3 Il8 inhibitors |
| 04/13/1995 | WO1995007718A3 Purine nucleoside phosphorylase gene therapy for human malignancy |
| 04/13/1995 | WO1995006727A3 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease |
| 04/13/1995 | CA2173625A1 Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained |
| 04/13/1995 | CA2173495A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines |
| 04/13/1995 | CA2133872A1 Molecules influencing the shedding of the tnf receptor, their preparation and their use |
| 04/12/1995 | EP0647655A1 Synthetic peptides and vaccines against parvovirus |
| 04/12/1995 | EP0647275A1 Cloning and expression of gonadotropin-releasing hormone receptor |
| 04/12/1995 | EP0647272A1 Anti-hiv proteins gap 31, dap 30 and dap 32, dna coding therefor and therapeutic uses thereof |
| 04/12/1995 | EP0647270A1 Novel malignant cell type markers of the interior nuclear matrix |
| 04/12/1995 | EP0647238A1 INTERLEUKIN-1$g(b) DELETION MUTANT |
| 04/12/1995 | EP0647140A1 Papillomavirus vaccines |
| 04/12/1995 | EP0647139A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) |
| 04/12/1995 | EP0647138A1 Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same |
| 04/12/1995 | EP0329737B1 Tri-aza macrocycles and metal complexes thereof |
| 04/12/1995 | CN1101289A Live combination vaccine |
| 04/11/1995 | US5405990 Chemical compounds |
| 04/11/1995 | US5405957 Wavelength-specific photosensitive compounds and expanded porphyrin-like compounds and methods of use |
| 04/11/1995 | US5405940 Isolated nonapeptides derived from MAGE genes and uses thereof |
| 04/11/1995 | US5405785 Derivatives of cyclosporine A, antibodies directed thereto and uses thereof |
| 04/11/1995 | US5405758 DNA encoding the recombinant 40 kDA Dermatophagoides farinae allergen |
| 04/11/1995 | US5405748 Purification of the Gal/GalNAc lectin from a nonpathogenic form of the parasite |
| 04/11/1995 | US5405618 Active materials bound at surface; used in immunoassays, bioseparations, enzyme-catalysed reactions; ionic, nonnionic and zwitterionic surface active agents to enhance binding |
| 04/11/1995 | CA1335182C Cellulose binding fusion proteins |
| 04/06/1995 | WO1995009249A1 Oral vaccination of mammals |
| 04/06/1995 | WO1995009241A2 Anti-cancer gene therapy by modulation of immune or inflammatory response |
| 04/06/1995 | WO1995009232A2 Peptides representing epitopic sites for bacterial and viral meningitis causing agents and their cns carrier, antibodies thereto, and uses thereof |
| 04/06/1995 | WO1995009186A1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas |
| 04/06/1995 | WO1995009182A1 Protective antigens against parasites |
| 04/06/1995 | WO1995009181A1 Peptide containing amino acid sequence of fimbrial protein of porphyromonas gingivalis and use thereof |
| 04/06/1995 | WO1995009180A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
| 04/06/1995 | WO1995009025A1 VACCINE FOR $i(BRANHAMELLA CATARRHALIS) |
| 04/06/1995 | WO1995009004A1 Compositions containing growth factors and antiplastic agents |
| 04/06/1995 | WO1995003417A3 Homologously recombinant slow growing mycobacteria and uses therefor |
| 04/06/1995 | CA2172729A1 Endothelial monocyte activating polypeptide ii: a mediator which activates host response |
| 04/06/1995 | CA2172728A1 Vaccine for branhamella catarrhalis |
| 04/06/1995 | CA2172492A1 Protective antigens against parasites |
| 04/06/1995 | CA2149657A1 Compositions containing growth factors and antiplastic agents |
| 04/05/1995 | EP0646793A2 Methods for utilizing cell lines which lack human class II histocompatibility antigens |
| 04/05/1995 | EP0646378A1 Agent for enhancing the yield of antibodies in immunology |
| 04/05/1995 | EP0646377A1 Albumin-conjugated tumour cell-free extracts, antigenic compositions comprising the same, related antibodies, and uses thereof |
| 04/05/1995 | EP0646376A1 Immunomodulating and antiinflammatory agent |
| 04/05/1995 | EP0646243A1 Detection of alzheimer's disease and other diseases using a photoaffinity labeling method |
| 04/05/1995 | EP0646178A1 expression cassette with regularoty regions functional in the mammmlian host |
| 04/05/1995 | EP0646176A1 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
| 04/05/1995 | EP0646175A1 RECOMBINANT $i(PSEUDOMONAS) EXOTOXIN WITH INCREASED ACTIVITY |
| 04/05/1995 | EP0646174A1 Recombinant production of saporin-containing proteins |
| 04/05/1995 | EP0646170A1 DIABETOGENE $i(rad): A TYPE II DIABETES SPECIFIC GENE |
| 04/05/1995 | EP0646019A1 Pretargeting methods and compounds |
| 04/05/1995 | EP0646017A1 Immune suppressive product |
| 04/05/1995 | EP0646016A1 Synthetic peptides for the treatment of myasthenia gravis |
| 04/05/1995 | EP0646015A1 Contraceptive vaccine |